IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biodexa Pharmaceuticals PLC

CUSIP: 59564R609 | 13 institutional holders

Quarters

Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Cubist Systematic Strategies, LLC265,993
0.0% of portfolio›$18.2K
Millennium Management LLC204,300
0.0% of portfolio›$14.0K
UBS Group AG142,208
0.0% of portfolio›$9.8K
Two Sigma Securities, LLC37,865
0.0% of portfolio›$2.6K
Baader Bank Aktiengesellschaft16,250
0.0% of portfolio›$865
Rhumbline Advisers2,370
0.0% of portfolio›$163
Morgan Stanley1,368
0.0% of portfolio›$94
Federation des caisses Desjardins du Quebec180
0.0% of portfolio›$12
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Cubist Systematic Strategies, LLC
265,993$18.2K0.0%ValueHighStamford, CT2023-08-14
Millennium Management LLC
204,300$14.0K0.0%CoreVery HighNew York, NY2023-08-14
UBS Group AG
142,208$9.8K0.0%CoreMediumZurich, Switzerland2023-08-11
Two Sigma Securities, LLC
37,865$2.6K0.0%ValueVery HighNew York, NY2023-08-14
Baader Bank Aktiengesellschaft
16,250$8650.0%CoreHighUnterschleissheim, Hong Kong2023-08-11
Rhumbline Advisers
2,370$1630.0%IndexVery LowBoston, MA2023-08-08
Morgan Stanley
1,368$940.0%CoreLowNew York, NY2023-08-14
Federation des caisses Desjardins du Quebec
180$120.0%ValueMediumLevis, Austria2024-08-15
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-08-10